Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma

European Journal of Endocrinology

Volumn 173, Issue 3, 2015, Pages 389-397

  Hoffmann, Anika ^a   Bootsveld, Klaus ^b   Gebhardt, Ursel ^a   Daubenbüchel, Anna M M ^a,c   Sterkenburg, Anthe S ^a,c   Müller, Hermann L ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

^b Radiologie Oldenburg   (Germany)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRANIOPHARYNGIOMA; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; FAT MASS; FATIGUE; FATTY LIVER; FEMALE; HUMAN; IMAGE ANALYSIS; LONG TERM CARE; MALE; NEAR INFRARED SPECTROSCOPY; NONALCOHOLIC FATTY LIVER; ONSET AGE; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVOR; ADIPOSE TISSUE; ADOLESCENT; COHORT ANALYSIS; COMPLICATION; ECHOGRAPHY; HYPOTHALAMIC NEOPLASMS; HYPOTHALAMUS; INJURIES; LIVER; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; PEDIATRIC OBESITY; PITUITARY NEOPLASMS; RADIOGRAPHY; YOUNG ADULT;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY COMPOSITION; COHORT STUDIES; CRANIOPHARYNGIOMA; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; HYPOTHALAMIC NEOPLASMS; HYPOTHALAMUS; LIVER; MALE; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; PEDIATRIC OBESITY; PITUITARY NEOPLASMS; SURVIVORS; YOUNG ADULT;

EID: 84940642748     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0422     Document Type: Article

References (47)

1. Muller HL. Craniopharyngioma. Endocrine Reviews 2014 35 513-543. (doi:10.1210/er.2013-1115)
2. Muller HL. Craniopharyngioma. Handbook of Clinical Neurology 2014 124 235-253. (doi:10.1016/B978-0-444-59602-4.00016-2)
3. Muller HL. Consequences of craniopharyngioma surgery in children. Journal of Clinical Endocrinology and Metabolism 2011 96 1981-1991. (doi:10.1210/jc.2011-0174)
4. Muller HL. Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nature Reviews. Endocrinology 2013 9 447-449. (doi:10.1038/nrendo.2013.125)
5. Muller HL. Childhood craniopharyngioma - current concepts in diagnosis, therapy and follow-up. Nature Reviews. Endocrinology 2010 6 609-618. (doi:10.1038/nrendo.2010.168)
6. Hoffmann A, Postma FP, Sterkenburg AS, Gebhardt U & Muller HL. Eating behavior, weight problems and eating disorders in 101 longterm survivors of childhood-onset craniopharyngioma. Journal of Pediatric Endocrinology & Metabolism 2015 28 35-43. (doi:10.1515/jpem-2014-0415)
7. Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM & Muller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-Oncology 2015 17 1029-1038. (doi:10.1093/neuonc/nov044)
8. Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG & Johannsson G. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. Journal of Clinical Endocrinology and Metabolism 2015 100 467-474. (doi:10.1210/jc.2014-3525)
9. Cohen M, Bartels U, Branson H, Kulkarni AV & Hamilton J. Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011. Neuro-Oncology 2013 15 767-774. (doi:10.1093/neuonc/not026)
10. Karavitaki N, Cudlip S, Adams CB & Wass JA. Craniopharyngiomas. Endocrine Reviews 2006 27 371-397. (doi:10.1210/er.2006-0002)
11. Gautier A, Godbout A, Grosheny C, Tejedor I, Coudert M, Courtillot C, Jublanc C, De Kerdanet M, Poirier JY, Riffaud L et al. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. Journal of Clinical Endocrinology and Metabolism 2012 97 1258-1267. (doi:10.1210/jc.2011-2817)
12. Kaur J. A comprehensive review on metabolic syndrome. Cardiology Research and Practice 2014 2014 943162. (doi:10.1155/2014/943162)
13. Bereket A, Kiess W, Lustig RH, Muller HL, Goldstone AP, Weiss R, Yavuz Y & Hochberg Z. Hypothalamic obesity in children. Obesity Reviews 2012 13 780-798. (doi:10.1111/j.1467-789X.2012.01004.x)
14. Than NN & Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015 239 192-202. (doi:10.1016/j.atherosclerosis.2015.01.001)
15. Cheung O & Sanyal AJ. Recent advances in nonalcoholic fatty liver disease. Current Opinion in Gastroenterology 2010 26 202-208. (doi:10.1097/MOG.0b013e328337b0c4)
16. Marchesini G, Moscatiello S, Di Domizio S & Forlani G. Obesityassociated liver disease. Journal of Clinical Endocrinology and Metabolism 2008 93 S74-S80. (doi:10.1210/jc.2008-1399)
17. Adams LA, Feldstein A, Lindor KD & Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 2004 39 909-914. (doi:10.1002/hep.20140)
18. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C & Charraud A. Body mass index variations: centiles from birth to 87 years. European Journal of Clinical Nutrition 1991 45 13-21.
19. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S & Lu DS. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004 230 276-280. (doi:10.1148/radiol.2301021176)
20. Shores NJ, LinkK, Fernandez A,GeisingerKR,DavisM,NguyenT, Sawyer J & Rudel L. Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients. Digestive Diseases and Sciences 2011 56 2145-2151. (doi:10.1007/s10620-011-1602-5)
21. Azizian H, Kramer JK, Heymsfield SB & Winsborough S. Fourier transform near infrared spectroscopy: a newly developed, non-invasive method to measure body fat: non-invasive body fat content measurement using FT-NIR. Lipids 2008 43 97-103. (doi:10.1007/s11745-007-3121-x)
22. Josse AR, Azizian H, French SB, Kramer JK & Phillips SM. Body fat content determination in premenopausal, overweight, and obese young women using DXA and FT-NIR. Obesity 2011 19 1497-1502. (doi:10.1038/oby.2011.39)
23. Noori N, Kovesdy CP, Bross R, Lee M, Oreopoulos A, Benner D, Mehrotra R, Kopple JD & Kalantar-Zadeh K. Novel equations to estimate lean body mass in maintenance hemodialysis patients. American Journal of Kidney Diseases 2011 57 130-139. (doi:10.1053/j.ajkd.2010.10.003)
24. Muller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R & Sorensen N. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes & Control 2006 17 583-589. (doi:10.1007/s10552-005-9012-7)
25. Milic S, Lulic D & Stimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World Journal of Gastroenterology 2014 20 9330-9337. (doi:10.3748/wjg.v20. i28.9330)
26. Fjalldal S, Holmer H, Rylander L, Elfving M, Ekman B, Osterberg K & Erfurth EM. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2013 98 3253-3262. (doi:10.1210/jc.2013-2000)
27. Erfurth EM, Holmer H & Fjalldal SB. Mortality and morbidity in adult craniopharyngioma. Pituitary 2013 16 46-55. (doi:10.1007/s11102-012-0428-2)
28. Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G & Muller HL. Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klinische Padiatrie 2014 226 161-168. (doi:10.1055/s-0034-1368785)
29. Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R & Sorensen N. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2004 89 3298-3305. (doi:10.1210/jc.2003-031751)
30. Erfurth EM. Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: growth hormone deficiency. Handbook of Clinical Neurology 2014 124 407-416. (doi:10.1016/B978-0-444-59602-4.00028-9)
31. Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kuhl J, Gutjahr P et al. Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of life. Klinische Padiatrie 2001 213 244-249. (doi:10.1055/s-2001-16855)
32. Hoffmann A, Gebhardt U, Sterkenburg AS, Warmuth-Metz M & Muller HL. Diencephalic syndrome in childhood craniopharyngioma -results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2014 99 3972-3977. (doi:10.1210/jc.2014-1680)
33. Muller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G & Sorensen N. Xanthogranuloma, Rathke's cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. Journal of Clinical Endocrinology and Metabolism 2012 97 3935-3943. (doi:10.1210/jc.2012-2069)
34. Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N & Calaminus G. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. European Journal of Endocrinology 2011 165 17-24. (doi:10.1530/EJE-11-0158)
35. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A & Haring HU. Identification and characterization of metabolically benign obesity in humans. Archives of Internal Medicine 2008 168 1609-1616. (doi:10.1001/archinte.168.15.1609)
36. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, Norris HT & Caro JF. Liver pathology in morbidly obese patients with and without diabetes. American Journal of Gastroenterology 1990 85 1349-1355.
37. El-Karaksy HM, El-Raziky MS, Fouad HM, Anwar GM, El-Mougy FM, El-Koofy NM & El-Hennawy AM. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. Diabetes & Metabolic Syndrome 2015 9 114-119. (doi:10.1016/j.dsx.2013.10.008)
38. Mahmoud AA, Bakir AS & Shabana SS. Serum TGF-b, serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD. Saudi Journal of Gastroenterology 2012 18 327-333. (doi:10.4103/1319-3767.101132)
39. Arata M, Nakajima J, Nishimata S, Nagata T & Kawashima H. Nonalcoholic steatohepatitis and insulin resistance in children. World Journal of Diabetes 2014 5 917-923. (doi:10.4239/wjd.v5.i6.917)
40. Idilman IS, Keskin O, Celik A, Savas B, Halil Elhan A, Idilman R & KarcaaltincabaM. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiologica 2015. In press.
41. Sharma A & Couture J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Annals of Pharmacotherapy 2014 48 209-225. (doi:10.1177/1060028013510699)
42. Muller HL, Muller-Stover S, Gebhardt U, Kolb R, Sorensen N & Handwerker G. Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. Journal of Pediatric Endocrinology & Metabolism 2006 19 (Suppl 1) 423-429.
43. Arcieri R,Germinario EA, Bonati M, MasiG, ZuddasA,Vella S, Chiarotti F & Panei P. Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine. Journal of Child and Adolescent Psychopharmacology 2012 22 423-431. (doi:10.1089/cap.2012.0014)
44. Martinez-Raga J, Knecht C, Szerman N & Martinez MI. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs 2013 27 15-30. (doi:10.1007/s40263-012-0019-9)
45. Tong HY, Diaz C, Collantes E, Medrano N, Borobia AM, Jara P & Ramirez E. Liver transplant in a patient under methylphenidate therapy: a case report and review of the literature. Case Reports in Pediatrics 2015 2015 437298. (doi:10.1155/2015/437298)
46. Muller HL, Handwerker G, Wollny B, Faldum A & Sorensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. Journal of Clinical Endocrinology and Metabolism 2002 87 3993-3996. (doi:10.1210/jcem.87.8.8751)
47. De Cruz S, Espiritu JR, Zeidler M & Wang TS. Sleep disorders in chronic liver disease. Seminars in Respiratory and Critical Care Medicine 2012 33 26-35. (doi:10.1055/s-0032-1301732)